Related Experiment Videos
[Dual function of NF-kappa B system during inflammation]
Pierre Desreumaux1, David Philippe
1Service des Maladies de l'Appareil Digestif et de la Nutrition, Equipe INSERM 0114, CHU, Lille.
Gastroenterologie Clinique Et Biologique
|January 21, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.
Journal of Crohn's & colitis·2026
Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational study.
Therapeutic advances in gastroenterology·2025
A Synbiotic Combining Chitin-Glucan and <i>Lactobacillus acidophilus</i> NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBS.
International journal of molecular sciences·2024
Fate of ileorectal anastomosis for treating Crohn's disease in the era of biologics: Results from a French retrospective multicentre cohort study.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2024
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026